The US Food and Drug Administration (FDA) has approved sipon
Vineesh Allenki
The US Food and Drug Administration (FDA) has approved siponimod (Mayzent®) tablets to treat adults with relapsing forms of multiple sclerosis(MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease (SPMS).
Like
Comment
Share